The SIMPLY-B Study
NCT05614466 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2022-11-14
Summary
This study will be conducted in three parts:
Part A: A prospective open label pilot intervention study, comparing the proportion of people with hepatitis B who are managed by their GP in primary care settings before, 12 months and 24 months after implementation of the Simply B electronic hepatitis B support package.
Part B: A nested qualitative health services feasibility study using semi -structured interviews and thematic analysis
Conditions
- Hepatitis B Virus Related Hepatocellular Carcinoma
Interventions
- OTHER
-
The Simply B Study
This study will be conducted in three parts: Part A: A prospective open label pilot intervention study, comparing the proportion of people with hepatitis B who are managed by their GP in primary care clinics before, 12 months and 24 months after implementation of the Simply B electronic hepatitis B support package. Part B: A nested qualitative health services feasibility study using semi -structured interviews and thematic analysis Part C: A mathematical modelling study using a Markov model to determine cost effectiveness of Simply B for increasing hepatitis B treatment uptake compared to status quo of hospital care.
Sponsors & Collaborators
-
Nadine Barnes
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-30
- Primary Completion
- 2025-06-30
- Completion
- 2025-10-31
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
NCT07137910 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
NCT05661786 ·Status: RECRUITING
-
A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients
NCT06115993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects
NCT05310487 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
NCT06216470 ·Status: RECRUITING ·Phase: PHASE2
-
A Nationwide Epidemiological, Educational Support Program for Improving Treatment Adherence in Patients With HBV
NCT01991262 ·Status: WITHDRAWN
-
A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
NCT07183306 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)
NCT06744686 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors
NCT04454567 ·Status: TERMINATED ·Phase: PHASE2
-
This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity
NCT06746311 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
NCT01813487 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
NCT07169656 ·Status: RECRUITING
-
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
NCT03361956 ·Status: COMPLETED ·Phase: PHASE2
-
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients
NCT03013556 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy
NCT02631096 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B
NCT01189656 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B
NCT03714152 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B
NCT00753467 ·Status: UNKNOWN ·Phase: PHASE2
-
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
NCT06926647 ·Status: NOT_YET_RECRUITING
-
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
NCT01590654 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).
NCT06550128 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
NCT05275465 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LP-128 Capsules in Healthy Subjects
NCT05130567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Plasma Purification and Chronic Hepatitis B
NCT04518553 ·Status: UNKNOWN ·Phase: NA